1. Home
  2. FHN vs RZLT Comparison

FHN vs RZLT Comparison

Compare FHN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Horizon Corporation

FHN

First Horizon Corporation

HOLD

Current Price

$24.53

Market Cap

11.0B

Sector

Finance

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.60

Market Cap

187.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHN
RZLT
Founded
1864
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
187.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FHN
RZLT
Price
$24.53
$2.60
Analyst Decision
Buy
Strong Buy
Analyst Count
18
6
Target Price
$24.61
$12.33
AVG Volume (30 Days)
5.7M
14.0M
Earning Date
01-15-2026
02-11-2026
Dividend Yield
2.44%
N/A
EPS Growth
20.88
N/A
EPS
1.65
N/A
Revenue
$3,184,000,000.00
N/A
Revenue This Year
$10.95
N/A
Revenue Next Year
$2.82
N/A
P/E Ratio
$14.83
N/A
Revenue Growth
3.68
N/A
52 Week Low
$15.19
$1.07
52 Week High
$24.75
$11.46

Technical Indicators

Market Signals
Indicator
FHN
RZLT
Relative Strength Index (RSI) 74.40 29.47
Support Level $23.54 $1.78
Resistance Level $24.10 $2.25
Average True Range (ATR) 0.44 0.58
MACD 0.11 -0.48
Stochastic Oscillator 93.16 13.27

Price Performance

Historical Comparison
FHN
RZLT

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: